Seo-Yeon Ahn

发表

Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On 18F-FDG PET/CT at Baseline.

C. Hong, S. Jeong, J. Min, 2021, Clinical lymphoma, myeloma & leukemia.

Prognostic impact of 18F-FDG PET/CT in patients with multiple myeloma presenting with renal impairment

C. Hong, S. Jeong, J. Min, 2021, International Journal of Hematology.

Updated recommendations for the treatment of venous thromboembolism

Hee-Jin Kim, Junshik Hong, J. Lee, 2021, Blood research.

Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen

J. Jo, H. Yhim, Je-Jung Lee, 2022, Blood research.

Novel IL-15 dendritic cells have a potent immunomodulatory effect in immunotherapy of multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2022, Translational oncology.

Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms.

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2022, Leukemia research.

Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts

Y. Lee, Yunsuk Choi, Y. Cho, 2018, Annals of Hematology.

A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System

Kihyun Kim, S. Kim, Jin Seok Kim, 2018, British journal of haematology.

Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2015, Blood research.

Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional Study

J. Cheong, Y. Lee, Y. Koh, 2019, In Vivo.

Quantitative Assessment of Interim PET/CT Could Have More Prognostic Relevance than Visual Assessment for Predicting Clinical Outcome of Extranodal Diffuse Large B Cell Lymphoma

C. Hong, S. Jeong, J. Min, 2020, In Vivo.

Successful Treatment of Crizotinib-Associated Severe Hepatotoxicity in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer

Youngchul Kim, I. Oh, Kyu-Sik Kim, 2014 .

Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas

Sae-Ryung Kang, H. Yhim, Je-Jung Lee, 2019, Annals of Hematology.

Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma

Kihyun Kim, S. Kim, S. Yoon, 2020, BMC Cancer.

Treatment of BK virus-associated hemorrhagic cystitis with low-dose intravenous cidofovir in patients undergoing allogeneic hematopoietic cell transplantation

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2015, The Korean journal of internal medicine.

Venetoclax with Azacitidine Induced Tumor Lysis Syndrome in an Elderly Patient with Acute Myeloid Leukemia: A Case Report

Sung-Hoon Jung, Jae-Sook Ahn, H. Bang, 2021, Electrolytes & Blood Pressure : E & BP.

Next‐generation sequencing‐based analysis to assess the pattern of relapse in patients with Philadelphia‐positive acute lymphoblastic leukemia

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2022, EJHaem.

Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21

Junsang Doh, Je-Jung Lee, Hyeoung-Joon Kim, 2021, Cancer Immunology, Immunotherapy.

Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study

Kihyun Kim, S. Kim, Je-Jung Lee, 2014, Annals of Hematology.

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia

Zhaolei Zhang, C. Jung, Je-Jung Lee, 2022, Bone Marrow Transplantation.

Impact of Consolidation Cycles Before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission

Y. Lee, Je-Jung Lee, Hyeoung-Joon Kim, 2018, Clinical lymphoma, myeloma & leukemia.

Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, BioMed research international.

Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2022, Cancer Immunology, Immunotherapy.

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2019, BMC Cancer.

Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma

Je-Jung Lee, Hyeoung-Joon Kim, Sang‐Yun Song, 2021, Journal of Korean medical science.

Diagnostic accuracy and prognostic relevance of immunoglobulin heavy chain rearrangement and 18 F-FDG- PET/CT compared with unilateral bone marrow trephination for detecting bone marrow involvement in patients with diffuse large B-cell lymphoma

Hyeoung-Joon Kim, Je Jung Lee, Deok-Hwan Yang, 2021 .

Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2021, Cellular & Molecular Immunology.

STAT3 expression is associated with poor survival in non-elderly adult patients with newly diagnosed multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, M. Shin, 2017, Blood research.

Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.

Marc S. Tyndel, Zhaolei Zhang, Y. Lee, 2018, Blood.

Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma

Deok-Hwan Yang, Ga-Young Song, Seo-Yeon Ahn, 2016, Blood research.

Prevalence and Risk Factors for Adrenal Insufficiency in Patients with Multiple Myeloma Receiving Long-Term Chemotherapy including Corticosteroids: A Retrospective Cohort Study

Ho-Cheol Kang, Wonsuk Choi, H. Kim, 2021, BioMed Research International.

Frontline therapy for newly diagnosed patients with multiple myeloma

J. Jo, Je-Jung Lee, Hyeoung-Joon Kim, 2019, Blood research.

Adrenal insufficiency in hospitalized patients with multiple myeloma

Ho-Cheol Kang, H. Kim, Je-Jung Lee, 2020, Leukemia & lymphoma.

Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2019, BMC Cancer.

Allogeneic transplant can abrogate the risk of relapse in the patients of first remission acute myeloid leukemia with detectable measurable residual disease by next-generation sequencing

Zhaolei Zhang, Je-Jung Lee, Hyeoung-Joon Kim, 2020, Bone Marrow Transplantation.

Decreased body mass index is associated with poor prognosis in patients with multiple myeloma

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2014, Annals of Hematology.

Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea

Jinny Park, J. H. Lee, J. Cheong, 2022, Blood research.

Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.

Zhaolei Zhang, S. Ogawa, Kenichi Yoshida, 2019, Experimental hematology.

18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System

J. Min, Je-Jung Lee, H. Bom, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia

M. Minden, C. Jung, Je-Jung Lee, 2016, Oncotarget.

Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma

J. Min, Je-Jung Lee, H. Bom, 2018, Clinical nuclear medicine.

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine

Je-Jung Lee, Hyeoung-Joon Kim, Deok-Hwan Yang, 2023, The Korean journal of internal medicine.

RNA sequencing as an alternative tool for detecting measurable residual disease in core-binding factor acute myeloid leukemia

Marc S. Tyndel, Zhaolei Zhang, J. Cheong, 2020, Scientific Reports.

Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype

Zhaolei Zhang, C. Jung, Y. Lee, 2017, Oncotarget.

Clinical Significance of bZIP In-Frame CEBPA-Mutated Normal Karyotype Acute Myeloid Leukemia

C. Jung, Je-Jung Lee, Hyeoung-Joon Kim, 2023, Cancer research and treatment : official journal of Korean Cancer Association.

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia

J. Cheong, Jae-Sook Ahn, J. Moon, 2024, Scientific reports.